Company signals · Biotech & Pharma
BioNTech
1 signal in the current window, with MitchelLake's leadership read on each.
Last updated
Market context: The wider read — a Talent Market Index of 95.4 (Cool), down 5.3 month-on-month — shows EMEA signal flow rising (+5pts).
BioNTech: 1 signal in the last 90 days — in line with the Biotech & Pharma median of 1 across 30 tracked companies.
Signals at BioNTech
Executive hires, departures and board changes at BioNTech
Every leadership-change and senior-hiring signal observed at BioNTech, newest first, each dated and linked to the source record.
BioNTech signals in the last 90 days
1 public signal observed since 19 August 2026, by type.
More signals across Biotech & Pharma
Leadership Change · EMEA
Harbour BioMed →Harbour BioMed (HKEX: 02142) appointed Vivian Feng as Head of External Collaboration, a new senior role overseeing partnerships with external parties.
Leadership Change · EMEA
BioMarin Pharmaceutical Inc. →Ian T. Clark elected as new Chair of the Board, replacing retiring Richard A. Meier
Capital Raising · EMEA
Neobe Therapeutics →UK biotech Neobe Therapeutics raised $6.8M (£5M) in seed funding led by ARC Ventures, with participation from Faber, Macmillan Ventures, Proven Connect and Empirical Ventures, to advance its NEO22 engineered-bacteria cancer program toward an IND filing in 2028.
Capital Raising · EMEA
mbiomics →mbiomics secured a further €12M, bringing its Series A to €30M to advance microbiome-based therapeutics (as reported in a roundup of European biotech financings).
Geographic Expansion · EMEA
Bio-Techne →Bio-Techne is expanding its GMP manufacturing network with a new facility in Bristol, UK, to scale cell therapy development capabilities alongside existing North American operations.
Product Launch · EMEA
AviadoBio →AviadoBio has presented Phase 1/2 trial data for AVB-101, its investigational gene therapy for frontotemporal dementia with GRN mutations (FTD-GRN), showing dose-dependent increases in cerebrospinal fluid progranulin levels across four ascending doses.
Where BioNTech's market lands in our work
- Board Search & Advisory →
Incoming executives reshape governance needs within two quarters.
- Executive Search: EMEA →
Our EMEA practice runs the searches behind signals like this one.
Intelligence powered by Autonodal ↗
Nearby in the record
- Data period
- 13 Nov 2026 – 13 Nov 2026 · 1 signals for this company
- Methodology
- How this is computed
- Publisher
- MitchelLake
Last updated
